Recombinant PCSK9 (Lodelcizumab Biosimilar) 抗体
This anti-PCSK9 (Lodelcizumab Biosimilar) antibody is a Mammalian Cells 单克隆 antibody detecting PCSK9 (Lodelcizumab Biosimilar) in ELISA. Suitable for 人.
产品编号 ABIN7488018
发货至:
中国
Contact our Customer Service for availability and price in your country.
Contact Info
Our Local Distributor
中国
北京 101111
北京 101111
No. 88 KeChuang 6th Street
Beijing Economic Technological Development Area
Room 801-803
Quick Overview for Recombinant PCSK9 (Lodelcizumab Biosimilar) 抗体 (ABIN7488018)
抗原
PCSK9 (Lodelcizumab Biosimilar)
抗体类型
Recombinant Antibody
适用
人
宿主
Mammalian Cells
克隆类型
单克隆
标记
This PCSK9 (Lodelcizumab Biosimilar) antibody is un-conjugated
应用范围
ELISA
质量等级
Research Grade
-
-
Expression System
- Mammalian cells
-
原理
- Lodelcizumab Biosimilar - Anti-PCSK9 mAb
-
产品特性
- Antibody Type: IgG1-kappa
-
纯化方法
- Recombinant antibody expressed in mammalien cells and purified.
-
亚型
- IgG1 kappa
-
-
-
-
限制
- 仅限研究用
-
-
-
缓冲液
- PBS pH 7.5
-
储存条件
- -80 °C
-
储存方法
- store at -80°C
-
-
- PCSK9 (Lodelcizumab Biosimilar)
-
物质类
- Biosimilar
-
背景
-
LGT209,NVP-LGT209
Ligelizumab (QGE031) is a humanized monoclonal antibody (mAb) designed for the treatment of severe asthma and chronic spontaneous urticaria. -
CAS-编号
- 1355338-54-3
抗原
-
You are here:
